ArticleClinical and translational medicine2021

Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.

Huafeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.